Crocin-I mitigates diquat-induced pulmonary fibrosis via activation of the SIRT3/FOXO3a pathway
These findings suggest that crocin-I activates the SIRT3/FOXO3a pathway and alleviates DQ-induced pulmonary fibrosis, highlighting its potential as a therapeutic agent for lung injury and paving the way for further research into its clinical applications.
Authors
- Weijun Chen (ORCID: https://orcid.org/0000-0002-1260-3488)
- Xiuli Li (ORCID: https://orcid.org/0000-0002-9109-8298)
- Yong Cao (ORCID: https://orcid.org/0000-0003-0128-0553)
- Yong Ke
- Shuangyun Xi
Institutions
- Zunyi Medical University (CN)
Publication Details
- Journal
- Biomedicine & Pharmacotherapy
- Published
- 2025-04-08
- DOI
- https://doi.org/10.1016/j.biopha.2025.118043
- Citations
- 2
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 3.04